Sunday, February 11, 2018

Remyelination and MS

From Stem Cells and Cloning: Advances and Applications » Volume 11

A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells

Published 12 February 2018 Volume 2018:11 Pages 1—11

From within the abstract:

Recent research has shown that cellular therapies hold a potential for CNS repair and may be able to provide protection from inflammatory damage caused after injury. Human embryonic stem cell (hESC) transplantation is one of the promising cell therapies; hESCs play an important role in remyelination and help in preventing demylenation of the axons. In this study, an overview of the current knowledge about the unique properties of hESC and their comparison with other cell therapies has been presented for the treatment of patients with MS.

Note US published application 20180010098

Elsewhere, Gold Nanocrystals May Remyelinate Lesions in Multiple Sclerosis

Recall IPBiz post:
Gold nanoparticles and Curley paper


Post a Comment

<< Home